Precision therapies for cancer and rare diseases

At Blueprint Medicines, we work together toward one common goal: to develop breakthrough precision medicines that allow patients to live longer, healthier lives.

Medical professionals
“Our team is comprised of scientific pioneers with profound expertise in protein kinases and clinical experts in cancer and rare diseases. Together, we aim to rapidly design and develop transformative precision therapies for patients in need.”
Andy Boral, M.D., Ph.D., Chief Medical Officer
Our platform

Our platform

Our world-leading expertise in protein kinases, which are proven drivers of disease, powers the relentless development of transformational medicines. We believe our progress in the clinic reflects the power of our platform to rapidly and reproducibly pursue highly selective kinase medicines against diverse, difficult-to-drug targets.

Read more about our scientific platform

Our commitment to patients

Patients are at the center of Blueprint Medicines’ mission to discover, develop and deliver innovative medicines that address significant medical needs. Through conducting rigorous clinical trials and successfully registering our medicines with global health authorities, we aim to bring innovative treatments to the greatest number of patients who may benefit, as quickly and responsibly as possible.

Learn about our ongoing clinical trials Read our policy on compassionate use